Ubrogepant for the acute treatment of migraine when administred during the prodrome: Results from a phase 3, randomized, double-blind, placebo-controlled, crossover study
JOURNAL OF THE NEUROLOGICAL SCIENCES（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要